Evaluation of the Carcinogenic Potential of Pharmaceuticals

This publication has 27 references indexed in Scilit:

• The International Life Sciences Institute's Role in the Evaluation of Alternative Methodologies for the Assessment of Carcinogenic Risk
  Toxicologic Pathology, 1998
• Use of transgenic animals in carcinogenesis studies
  Molecular Carcinogenesis, 1996
• The case for an upper dose limit of 1000 mg/kg in rodent carcinogenicity tests
  Cancer Letters, 1995
• Transgenic Animals in Toxicology
  Fundamental and Applied Toxicology, 1994
• The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
• Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme
  Carcinogenesis: Integrative Cancer Research, 1991
• Role of Persistent, Non-Genotoxic Tissue Damage in Rodent Cancer and Relevance to Humans
  Annual Review of Pharmacology and Toxicology, 1991
• An appreciation of the maximum tolerated dose: An inadequately precise decision point in designing a carcinogenesis bioassay?
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1991
• Interspecies extrapolation in carcinogenesis: prediction between rats and mice.
  Environmental Health Perspectives, 1989
• Patterns of tumor incidence in two-year cancer bioassay feeding studies in fischer 344 rats
  Fundamental and Applied Toxicology, 1983